Sanofi,Hanmi Announce License Agreement to Develop Portfolio Of Long-Acting Diabetes Treatments

By: via Benzinga
Sanofi (NYSE: SNY) and Hanmi Pharmaceutical Co., Ltd. announced today a worldwide license agreement to develop a portfolio of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.